The assessment of antibody response following immunization with polysaccharide vaccine in patients with chronic kidney disease

Tehran University Medical Journal

Volumn 69, Issue 2, 2011, Pages 92-98

  Aghamohammadi, Asghar ^b   Mahmoodi, Majid ^a   Rezaei, Nima ^b,c   Safari, Zahra ^a   Heidarnasab, Daryoush ^a   Divsalar, Kouros ^d   Mohagheghi, Mohammad Ali ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antibody response; Chronic kidney disease; Polysaccharide vaccine

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; PNEUMOCOCCUS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH RISK PATIENT; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 79957958051     PISSN: 16831764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Johnson DW, Fleming SJ. The use of vaccines in renal failure. Clin Pharmacokinet 1992;22(6):434-46.
2. Kausz AT, Gilbertson DT. Overview of vaccination in chronic kidney disease. Adv Chronic Kidney Dis 2006;13(3):209-14.
3. Chatenoud L, Herbelin A, Beaurain G, Descamps-Latscha B. Immune deficiency of the uremic patient. Adv Nephrol Necker Hosp 1990;19:259-74.
4. Linnemann CC Jr, First MR. Risk of pneumococcal infections in renal transplant patients. JAMA 1979;241(24):2619-21.
5. Rytel MW, Dailey MP, Schiffman G, Hoffmann RG, Piering WF. Pneumococcal vaccine immunization of patients with renal impairment. Proc Soc Exp Biol Med 1986;182(4):468-73.
6. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001;120(6):1883-7.
7. Khan SS, Kazmi WH, Abichandani R, Tighiouart H, Pereira BJ, Kausz AT. Health care utilization among patients with chronic kidney disease. Kidney Int 2002;62(1):229-36.
8. United States Renal Data System: USRDS. Annual Data Report. The National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2004.
9. Khan IH, Catto GR. Long-term complications of dialysis: infection. Kidney Int Suppl 1993;41:S143-8.
10. Pazik J, Durlik M, Lewandowska D, et al. Pneumonia in kidney allograft recipients. Transplant Proc 2003; 35:2202-204.
11. Pourfarziani V, Ramezani MB, Taheri S, Izadi M, Einollahi B. Immunogenicity of pneumococcal vaccination in renal transplant recipients and hemodialysis patients: a comparative controlled trial. Ann Transplant 2008;13(3):43-7.
12. Fuchshuber A, Kühnemund O, Keuth B, Lütticken R, Michalk D, Querfeld U. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol Dial Transplant 1996;11(3):468-73.
13. Linnemann CC Jr, First MR, Schiffman G. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med 1986;146(8):1554-6.
14. Kazancioǧlu R, Sever MS, Yüksel-Onel D, Eraksoy H, Yildiz A, Celik AV, et al. Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine. Clin Transplant 2000;14(1):61-5.
15. Simberkoff MS, Schiffman G, Katz LA, Spicehandler JR, Moldover NH, Rahal JJ Jr. Pneumococcal capsular polysaccharide vaccination in adult chronic hemodialysis patients. J Lab Clin Med 1980;96(2):363-70.
16. Nikoskelainen J, Koskela M, Forsström J, Kasanen A, Leinonen M. Persistence of antibodies to pneumococcal vaccine in patients with chronic renal failure. Kidney Int 1985;28(4):672-7.
17. Shapiro ED, Berg AT, Austrian R, Schroeder D, Parcells V, Margolis A, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325(21):1453-60.
18. Wernette CM, Frasch CE, Madore D, Carlone G, Goldblatt D, Plikaytis B, et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol 2003;10(4):514-9.
19. Aghamohammadi A, Moin M, Karimi A, Naraghi M, Zandieh F, Isaeian A, et al. Immunologic evaluation of patients with recurrent ear, nose, and throat infections. Am J Otolaryngol 2008;29(6):385-92. Epub 2008 Jun 16.
20. Tabatabaie P, Aghamohammadi A, Mamishi S, Isaeian A, Heidari G, Abdollahzade S, et al. Evaluation of humoral immune function in patients with bronchiectasis. Iran J Allergy Asthma Immunol 2008;7(2):69-77.
21. Skorliakov AV, Bystrenin MA, Voloshinova EV. The character and structure of infectious complications in patients with chronic renal failure, who received or did not receive replacement therapy (hemodialysis). Klin Med (Mosk) 2007;85(10):59-61.
22. Rangel MC, Coronado VG, Euler GL, Strikas RA. Vaccine recommendations for patients on chronic dialysis. The Advisory Committee on Immunization Practices and the American Academy of Pediatrics. Semin Dial 2000;13(2):101-7.
23. Cosio FG, Giebink GS, Le CT, Schiffman G. Pneumococcal vaccination in patients with chronic renal disease and renal allograft recipients. Kidney Int 1981;20(2):254-8.
24. Ambrosino DM, Umetsu DT, Siber GR, Howie G, Goularte TA, Michaels R, et al. Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels. J Allergy Clin Immunol 1988;81(6):1175-9.
25. Dengler TJ, Strnad N, Zimmermann R, Allers C, Markus BH, Nessen SV, et al. Pneumococcal vaccination after heart and liver transplantation. Immune responses in immunosuppressed patients and in healthy controls. Dtsch Med Wochenschr 1996;121(49):1519-25.
26. Simberkoff MS, Cross AP, Al-Ibrahim M, Baltch AL, Geiseler PJ, Nadler J, et al. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986;315(21):1318-27.
27. Farr BM, Johnston BL, Cobb DK, Fisch MJ, Germanson TP, Adal KA, et al. Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study. Arch Intern Med 1995;155(21):2336-40.
28. Rodriguez-Barradas MC, Groover JE, Lacke CE, Gump DW, Lahart CJ, Pandey JP, et al. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J Infect Dis 1996;173(6):1347-53.
29. Petrasch S, Kühnemund O, Reinacher A, Uppenkamp M, Reinert R, Schmiegel W, et al. Antibody responses of splenectomized patients with non-Hodgkin's lymphoma to immunization with polyvalent pneumococcal vaccines. Clin Diagn Lab Immunol 1997;4(6):635-8.
30. Zielen S, Bühring I, Strnad N, Reichenbach J, Hofmann D. Immunogenicity and tolerance of a 7-valent pneumococcal conjugate vaccine in nonresponders to the 23-valent pneumococcal vaccine. Infect Immun 2000;68(3):1435-40.